Insider Trading History of Koppel Adam

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Koppel Adam since 2013. This trader's CIK number is 1578965. At the time of last reporting, Koppel Adam was the Director of Cerevel Therapeutics Holdings, Inc.. (stock ticker symbol CERE). Also see all insider trading activities at Cerevel Therapeutics Holdings, Inc..

Note that in the past Koppel Adam also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Marinus Pharmaceuticals, Inc. (MRNS) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 MRNS 0 $0 1,272,547 $10,205,298 0 $0

Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 DRNA 0 $0 1,000,000 $23,400,000 0 $0
2019 DRNA 0 $0 4,850,000 $95,572,500 0 $0
2017 DRNA 285,000 $1,995,000 0 $0 8,454,388 $0

Yearly summary of insider trading at Solid Biosciences Inc. (SLDB) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 SLDB 300,000 $4,800,000 0 $0 1,689,444 $0

Yearly summary of insider trading at Cerevel Therapeutics Holdings, Inc. (CERE) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 CERE 5,480,052 $124,999,986 0 $0 0 $0
2020 CERE 10,332,293 $103,422,617 0 $0 0 $0

Yearly summary of insider trading at Biogen Inc. (BIIB) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 BIIB 0 $0 657 $189,000 1,643 $0
2015 BIIB 0 $0 0 $0 2,384 $0

Yearly summary of insider trading at Ptc Therapeutics, Inc. (PTCT) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 PTCT 1,250,000 $18,750,000 0 $0 0 $0

Yearly summary of insider trading at Aptinyx Inc. (APTX) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 APTX 6,666,666 $19,999,998 0 $0 0 $0
2018 APTX 400,000 $6,400,000 0 $0 0 $0

Yearly summary of insider trading at Springworks Therapeutics, Inc. (SWTX) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 SWTX 0 $0 2,450,000 $173,925,000 0 $0
2019 SWTX 150,000 $2,700,000 0 $0 0 $0

Yearly summary of insider trading at Replimune Group, Inc. (REPL) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 REPL 500,000 $7,500,000 0 $0 0 $0

Yearly summary of insider trading at Rapid Micro Biosystems, Inc. (RPID) by Koppel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 RPID 100,000 $2,000,000 0 $0 0 $0


Insider trading activities at 10 companies by Koppel Adam:

1. Marinus Pharmaceuticals, Inc. (MRNS)

2. Dicerna Pharmaceuticals Inc (DRNA)

3. Solid Biosciences Inc. (SLDB)

4. Cerevel Therapeutics Holdings, Inc. (CERE)

5. Biogen Inc. (BIIB)

6. Ptc Therapeutics, Inc. (PTCT)

7. Aptinyx Inc. (APTX)

8. Springworks Therapeutics, Inc. (SWTX)

9. Replimune Group, Inc. (REPL)

10. Rapid Micro Biosystems, Inc. (RPID)

Table 1. Insider trading of Marinus Pharmaceuticals, Inc. (MRNS) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-12-19 MRNS Sale 150,000 7.36 1,104,450
2017-12-18 MRNS Sale 300,000 7.50 2,251,500
2017-12-15 MRNS Sale 822,547 8.33 6,849,348

Table 2. Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-10 DRNA Sale 1,000,000 23.40 23,400,000
2019-12-04 DRNA Sale 1,500,000 24.68 37,020,000
2019-11-19 DRNA Sale 1,750,000 22.03 38,552,500
2019-05-29 DRNA Sale 1,600,000 12.50 20,000,000
2017-12-18 DRNA Option Ex 8,454,388 .00 0
2017-12-18 DRNA Buy 285,000 7.00 1,995,000

Table 3. Insider trading of Solid Biosciences Inc. (SLDB) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-01-30 SLDB Buy 300,000 16.00 4,800,000
2018-01-25 SLDB Option Ex 1,689,444 .00 0

Table 4. Insider trading of Cerevel Therapeutics Holdings, Inc. (CERE) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-10-16 CERE Buy 5,480,052 22.81 124,999,986
2020-11-09 CERE Buy 332,293 10.30 3,422,617
2020-10-27 CERE Buy 10,000,000 10.00 100,000,000

Table 5. Insider trading of Biogen Inc. (BIIB) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-06-06 BIIB Sale 555 290.00 160,950
2016-06-02 BIIB Option Ex 1,643 .00 0
2016-04-06 BIIB Sale 102 275.00 28,050
2015-06-02 BIIB Option Ex 2,384 .00 0

Table 6. Insider trading of Ptc Therapeutics, Inc. (PTCT) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-06-25 PTCT Buy 1,250,000 15.00 18,750,000

Table 7. Insider trading of Aptinyx Inc. (APTX) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-10-26 APTX Buy 3,333,333 3.00 9,999,999
2020-01-14 APTX Buy 3,333,333 3.00 9,999,999
2018-06-25 APTX Buy 400,000 16.00 6,400,000

Table 8. Insider trading of Springworks Therapeutics, Inc. (SWTX) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-08-10 SWTX Sale 1,000,000 70.25 70,250,000
2021-03-09 SWTX Sale 1,450,000 71.50 103,675,000
2019-09-17 SWTX Buy 150,000 18.00 2,700,000

Table 9. Insider trading of Replimune Group, Inc. (REPL) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-24 REPL Buy 500,000 15.00 7,500,000

Table 10. Insider trading of Rapid Micro Biosystems, Inc. (RPID) by Koppel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-07-19 RPID Buy 100,000 20.00 2,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Koppel Adam (Director of Cerevel Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.